Matching qpcr reagents to the instrument and the question: how a qpcr machine, qpcr instruments, a real time pcr instrument, a real time pcr system and real time pcr machines differ on optics and block uniformity rather than on speed, where an automated thermal cycler, an automated pcr machine, automated pcr generally, a thermocycler machine, a thermal cycler for pcr, a pcr thermal cycler, a gradient pcr machine and a gradient thermocycler still earn their place among the other chemistry instruments on the bench, what a qpcr master mix, a qpcr kit, qpcr kits and one step qpcr chemistry each assume about your template, how a qpcr primer, primers for qpcr, primers qpcr design and a qpcr standard decide whether a curve means anything, why qpcr controls are the part that makes a result reportable, and what microrna qpcr, mirna qpcr and qpcr mrna work demand that a standard protocol does not

A quantitative amplification result is a number produced by an instrument, a chemistry, a primer design and a set of controls acting together, and weakness in any one of them is invisible in the output. Instruments are usually chosen on throughput and speed, which are the least important properties. This page sets out what actually determines whether the numbers are trustworthy.

laboratory records, the clause behind a reportable amplification result
211.194
good laboratory practice for nonclinical studies, 21 CFR
Part 58
the labelling clause behind research use only on an amplification reagent
809.10(c)

The figures in this panel are regulation identifiers, named from the regulations themselves and linked below. They are not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a reagent price index it has not measured.

Specifying the platform and the chemistry

  1. Check block uniformity before anything else. If wells at the edge of the block run at a different temperature from the centre, every plate carries a position effect that looks like biology. Ask for uniformity data and, better, run a uniform plate of the same sample across all wells during evaluation.
  2. Match the optics to the dyes you will actually use. Excitation and emission channels determine which reporter and quencher combinations work and how many targets can be multiplexed. A platform with an attractive channel count that omits the dye your assays are built on is an expensive migration.
  3. Choose intercalating dye or probe chemistry deliberately. A dye based mix is cheap and flexible and reports any double stranded product including primer artefacts, which is why a melt analysis is mandatory with it. Probe chemistry adds specificity and multiplexing at a higher per reaction cost. Decide per assay rather than per laboratory.
  4. Design primers against the target's structure. Span an intron where genomic contamination is possible, check for secondary structure and for annealing to related sequences, and validate with a dilution series that gives an efficiency inside an acceptable band. Primers that were never validated are the commonest cause of an unreproducible result.
  5. Decide one step against two step for RNA targets. One step reduces handling and contamination risk and suits routine panels. Two step lets one reverse transcription serve many targets and gives a stable complementary DNA stock, which suits exploratory work and precious samples.
  6. Write the control set into the protocol. No template controls on every plate, no reverse transcription controls where RNA is the input, an inter plate calibrator where results are compared across runs, and reference targets chosen by stability in your own samples rather than by tradition.

Efficiency is the number to demand

An assay's amplification efficiency, measured from a dilution series, tells you whether the arithmetic behind a relative quantitation is valid. Assays outside an acceptable efficiency band produce fold changes that are systematically wrong, and no amount of replication corrects that.

Measure it once per assay per matrix, record it with the assay, and repeat it when the mix, the primers or the instrument changes. It is a half day that prevents months of unreliable data.

Contamination control is a layout problem

Amplified product is the contaminant, and it travels on gloves, pipettes and air. The effective controls are physical: separate areas or at least separate times for reagent preparation, template addition and post amplification handling, dedicated equipment and a strict direction of travel.

A laboratory that has had a contamination event and cannot say where it came from has a layout problem rather than a reagent problem, and buying a new mix will not solve it.

Small RNA targets are a different assay

Short targets cannot accommodate conventional primer pairs, so they require a stem loop or tailing based approach that converts them into an amplifiable template. The chemistry, the normalisation strategy and the controls all differ from messenger targets.

Treat those panels as a separate method with their own validation rather than as a variation of the standard protocol, and choose references from the same class of molecule.

Common questions

Does the instrument or the chemistry matter more?
The chemistry and the primer design dominate result quality; the instrument mostly contributes block uniformity and optical sensitivity. A well designed assay runs acceptably on most modern instruments, and a poorly designed one fails on all of them.
How should reference targets be chosen?
Empirically, by measuring candidate references across your own experimental conditions and selecting those that do not change. Using a conventional housekeeping target without checking it is a frequent and invisible source of error.
Is a melt curve always necessary?
With intercalating dye chemistry, yes, because the dye reports any double stranded product including primer dimers. With probe chemistry it is unnecessary for specificity but remains a useful diagnostic during assay development.
When is a gradient block still useful?
During assay development, where a temperature gradient across the block finds the annealing optimum in one run. For routine running of validated assays it adds nothing, which is why many laboratories keep one older gradient instrument alongside their production platform.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/qpcr-reagents/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices